-
Symbol
-
DAWN on Nasdaq
-
Investment type
-
Equity / Common Stock, par value $0.0001 per share
-
Latest Disclosed Shares Owned
-
5,849,917 shares
-
Security Ownership %
-
5.8%
Shares, Excluding Options vs Price
BlackRock, Inc. ownership in Day One Biopharmaceuticals, Inc. Common Stock, par value $0.0001 per share (DAWN)
17 Jul 2025 - BlackRock, Inc. has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,849,917 shares of Day One Biopharmaceuticals, Inc. Common Stock, par value $0.0001 per share (DAWN).
This represents 5.8% ownership of the company.
In their previous filing dated 28 Apr 2025, BlackRock, Inc. had reported owning 4,812,307 shares, indicating an increase of +22%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.